Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-27 Sale | 2026-03-02 4:46 pm | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 10,000 | $144.79 | $1,447,859 | 642,308 (Direct) | View |
| 2026-02-17 Sale | 2026-02-18 5:22 pm | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Comm & Corp Aff Officer | 28,000 | $154.44 | $4,324,228 | 168,398 (Direct) | View |
| 2026-02-17 Sale | 2026-02-18 5:11 pm | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 3,000 | $154.43 | $463,290 | 167,779 (Direct) | View |
| 2026-02-05 Sale | 2026-02-06 4:22 pm | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 115,640 | $150 | $17,346,000 | 613,912 (Direct) | View |
| 2026-01-28 Sale | 2026-01-29 5:23 pm | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 10,000 | $139.89 | $1,398,911 | 556,698 (Direct) | View |
| 2026-01-23 Sale | 2026-01-26 7:29 pm | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 115,640 | $135 | $15,611,400 | 682,338 (Direct) | View |
| 2026-01-20 Sale | 2026-01-21 4:26 pm | GILEAD SCIENCES INC. | GILD | Bluestone Jeffrey Director | 5,000 | $123.5 | $617,500 | 13,585 (Direct) | View |
| 2026-01-15 Sale | 2026-01-16 6:18 pm | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 3,000 | $124.31 | $372,930 | 150,503 (Direct) | View |
| 2026-01-15 Sale | 2026-01-16 6:10 pm | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 3,000 | $124.31 | $372,930 | 103,221 (Direct) | View |
| 2025-12-29 Sale | 2025-12-30 4:23 pm | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 10,000 | $124.83 | $1,248,272 | 566,698 (Direct) | View |
| 2025-12-15 Sale | 2025-12-16 6:31 pm | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 3,000 | $122 | $366,000 | 153,503 (Direct) | View |
| 2025-12-15 Sale | 2025-12-16 6:12 pm | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 3,000 | $122 | $366,000 | 106,221 (Direct) | View |
| 2025-11-28 Sale | 2025-12-01 6:11 pm | GILEAD SCIENCES INC. | GILD | Bluestone Jeffrey Director | 5,000 | $125.08 | $625,400 | 16,568 (Direct) | View |
| 2025-11-26 Sale | 2025-12-01 4:54 pm | GILEAD SCIENCES INC. | GILD | Kramer Kelly A. Director | 5,611 | $127.11 | $713,186 | 4,144 (Direct) | View |
| 2025-11-28 Sale | 2025-12-01 4:50 pm | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 10,000 | $126.54 | $1,265,444 | 571,203 (Direct) | View |
| 2025-11-17 Sale | 2025-11-18 7:00 pm | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 2,500 | $125.23 | $313,075 | 154,555 (Direct) | View |
| 2025-11-17 Sale | 2025-11-18 6:51 pm | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 28,000 | $125.86 | $3,524,173 | 180,303 (Direct) | View |
| 2025-11-12 Sale | 2025-11-13 7:36 pm | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 53,646 | $122.85 | $6,590,487 | 106,285 (Direct) | View |
| 2025-10-28 Sale | 2025-10-29 4:14 pm | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 10,000 | $119.39 | $1,193,926 | 581,203 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-10 Exercise | 2026-03-12 4:45 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 6,469 | $0 | 269,775 (Direct) | View |
| 2026-03-10 Option Award | 2026-03-12 4:45 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 45,470 | $0 | 269,775 (Direct) | View |
| 2026-03-10 Tax Withholding | 2026-03-12 4:45 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 3,147 | $148.56 | 269,775 (Direct) | View |
| 2026-03-10 Exercise | 2026-03-12 4:42 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Comm & Corp Aff Officer | 6,617 | $0 | 222,363 (Direct) | View |
| 2026-03-10 Option Award | 2026-03-12 4:42 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Comm & Corp Aff Officer | 45,470 | $0 | 222,363 (Direct) | View |
| 2026-03-10 Tax Withholding | 2026-03-12 4:42 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Comm & Corp Aff Officer | 3,216 | $148.56 | 222,363 (Direct) | View |
| 2026-03-10 Exercise | 2026-03-12 4:39 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp | 1,246 | $0 | 60,061 (Direct) | View |
| 2026-03-10 Option Award | 2026-03-12 4:39 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp | 23,935 | $0 | 60,061 (Direct) | View |
| 2026-03-10 Tax Withholding | 2026-03-12 4:39 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp | 606 | $148.56 | 60,061 (Direct) | View |
| 2026-03-10 Option Award | 2026-03-12 4:37 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Burkhart Erin SVP, Controllership | 7,810 | $0 | 16,700 (Direct) | View |
| 2026-03-10 Exercise | 2026-03-12 4:24 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 20,026 | $0 | 944,225 (Direct) | View |
| 2026-03-10 Option Award | 2026-03-12 4:24 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 155,570 | $0 | 944,225 (Direct) | View |
| 2026-03-10 Tax Withholding | 2026-03-12 4:24 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 9,767 | $148.56 | 944,225 (Direct) | View |
| 2026-03-10 Exercise | 2026-03-12 4:22 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Berger Dietmar Chief Medical Officer | 2,133 | $0 | 136,964 (Direct) | View |
| 2026-03-10 Option Award | 2026-03-12 4:22 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Berger Dietmar Chief Medical Officer | 39,890 | $0 | 136,964 (Direct) | View |
| 2026-03-10 Tax Withholding | 2026-03-12 4:22 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Berger Dietmar Chief Medical Officer | 1,063 | $148.56 | 136,964 (Direct) | View |
| 2026-02-27 Option Award | 2026-03-02 4:57 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 11,090 | $0 | 178,869 (Direct) | View |
| 2026-02-27 Option Award | 2026-03-02 4:54 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Comm & Corp Aff Officer | 11,090 | $0 | 131,378 (Direct) | View |
| 2026-02-27 Option Award | 2026-03-02 4:51 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Berger Dietmar Chief Medical Officer | 8,530 | $0 | 17,912 (Direct) | View |
| 2026-02-27 Option Award | 2026-03-02 4:48 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp | 470 | $0 | 4,414 (Direct) | View |
| 2026-02-27 Option Award | 2026-03-02 4:46 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 38,396 | $0 | 642,308 (Direct) | View |
| 2026-02-17 Exercise | 2026-02-18 5:22 pm | N/A 2029-07-24 | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Comm & Corp Aff Officer | 25,000 | $0 | 168,398 (Direct) | View |
| 2026-02-17 Exercise | 2026-02-18 5:22 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Comm & Corp Aff Officer | 25,000 | $66.64 | 168,398 (Direct) | View |
Ownership | 2026-02-12 7:26 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp | 0 | $0 | 40,346 (Direct) | View |
| 2026-02-05 Exercise | 2026-02-06 4:22 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 115,640 | $66.01 | 613,912 (Direct) | View |
| 2026-02-05 Exercise | 2026-02-06 4:22 pm | N/A 2029-03-01 | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 115,640 | $0 | 613,912 (Direct) | View |
| 2026-02-03 Option Award | 2026-02-05 6:51 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Comm & Corp Aff Officer | 44,867 | $0 | 123,288 (Direct) | View |
| 2026-02-03 Tax Withholding | 2026-02-05 6:51 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Comm & Corp Aff Officer | 24,800 | $143.28 | 123,288 (Direct) | View |
| 2026-02-03 Option Award | 2026-02-05 6:49 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 44,867 | $0 | 170,568 (Direct) | View |
| 2026-02-03 Tax Withholding | 2026-02-05 6:49 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 24,802 | $143.28 | 170,568 (Direct) | View |
| 2026-02-03 Option Award | 2026-02-05 6:46 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 131,675 | $0 | 613,912 (Direct) | View |
| 2026-02-03 Tax Withholding | 2026-02-05 6:46 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 74,461 | $143.28 | 613,912 (Direct) | View |
| 2026-01-23 Exercise | 2026-01-26 7:29 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 115,640 | $66.01 | 682,338 (Direct) | View |
| 2026-01-23 Exercise | 2026-01-26 7:29 pm | N/A 2029-03-01 | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 115,640 | $0 | 682,338 (Direct) | View |
| 2026-01-20 Exercise | 2026-01-21 4:26 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Bluestone Jeffrey Director | 5,000 | $67.45 | 13,585 (Direct) | View |
| 2026-01-20 Exercise | 2026-01-21 4:26 pm | N/A 2031-05-12 | GILEAD SCIENCES INC. | GILD | Bluestone Jeffrey Director | 5,000 | $0 | 13,585 (Direct) | View |
| 2026-01-02 Tax Withholding | 2026-01-05 5:56 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Berger Dietmar Chief Medical Officer | 6,944 | $121.6 | 50,561 (Direct) | View |
| 2026-01-02 Exercise | 2026-01-05 5:56 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Berger Dietmar Chief Medical Officer | 16,326 | $0 | 50,561 (Direct) | View |
| 2025-12-10 Exercise | 2025-12-11 8:40 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 3,693 | $0 | 184,029 (Direct) | View |
| 2025-12-10 Tax Withholding | 2025-12-11 8:40 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 1,745 | $121.34 | 184,029 (Direct) | View |
| 2025-12-10 Exercise | 2025-12-11 8:38 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 10,426 | $0 | 664,768 (Direct) | View |
| 2025-12-10 Tax Withholding | 2025-12-11 8:38 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 4,931 | $121.34 | 664,768 (Direct) | View |
| 2025-12-10 Exercise | 2025-12-11 6:25 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 3,842 | $0 | 136,895 (Direct) | View |
| 2025-12-10 Tax Withholding | 2025-12-11 6:25 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 1,814 | $121.34 | 136,895 (Direct) | View |
| 2025-11-28 Exercise | 2025-12-01 6:11 pm | N/A 2034-05-08 | GILEAD SCIENCES INC. | GILD | Bluestone Jeffrey Director | 5,000 | $0 | 16,568 (Direct) | View |
| 2025-11-28 Exercise | 2025-12-01 6:11 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Bluestone Jeffrey Director | 5,000 | $64.92 | 16,568 (Direct) | View |
| 2025-11-26 Exercise | 2025-12-01 4:54 pm | N/A 2026-08-19 | GILEAD SCIENCES INC. | GILD | Kramer Kelly A. Director | 5,611 | $0 | 4,144 (Direct) | View |
| 2025-11-26 Exercise | 2025-12-01 4:54 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Kramer Kelly A. Director | 5,611 | $81 | 4,144 (Direct) | View |
| 2025-11-26 Exercise | 2025-12-01 4:36 pm | N/A N/A | Xilio Therapeutics Inc. | XLO | GILEAD SCIENCES INC. 10% Owner | 13,335,000 | $0.7499 | 36,645,266 (Direct) | View |
| 2025-11-26 Exercise | 2025-12-01 4:36 pm | 2025-11-01 N/A | Xilio Therapeutics Inc. | XLO | GILEAD SCIENCES INC. 10% Owner | 13,335,000 | $0 | 36,645,266 (Direct) | View |
| 2025-11-17 Exercise | 2025-11-18 6:51 pm | N/A 2029-07-24 | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 25,000 | $0 | 180,303 (Direct) | View |
| 2025-11-17 Exercise | 2025-11-18 6:51 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 25,000 | $66.64 | 180,303 (Direct) | View |
| 2025-11-12 Exercise | 2025-11-13 7:36 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 36,465 | $60.75 | 106,285 (Direct) | View |
| 2025-11-12 Exercise | 2025-11-13 7:36 pm | N/A 2034-03-10 | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 53,646 | $0 | 106,285 (Direct) | View |
| 2025-11-12 Exercise | 2025-11-13 7:36 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 17,181 | $75.12 | 106,285 (Direct) | View |
| 2025-10-25 Exercise | 2025-10-27 7:43 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 515 | $0 | 63,492 (Direct) | View |
| 2025-10-25 Tax Withholding | 2025-10-27 7:43 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 241 | $120.94 | 63,492 (Direct) | View |